Company overview

Novo Nordisk Asia Pacific Pte Ltd

UEN

199705347C

Name

Novo Nordisk Asia Pacific Pte Ltd

Former names

Novo Nordisk Health Care (Asia Pacific)

Entity type

Local Company

UEN Issue Date

1 August 1997

Secondary SSIC Code

70201

Status

Dissolved - Members Voluntary Winding Up

Incorporation date

1 August 1997

Address

238A, THOMSON ROAD, #16-06/08, NOVENA SQUARE

Postal Code

307684

Country

Singapore

Primary goods traded

  • 💉65.1% — Medicaments (300431)
  • 14.9% — Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues (293712)
  • 11.0% — Medicaments (300439)
  • 💊8.7% — Medicaments (300490)
  • 0.3% — Medical, surgical instruments and appliances (901832)
Main Trading Partners
PartnerTypeTotal ValuePercentage
PT Beta Pharmaconbuyer$348,291,41725.51%
PT Ferron Par Pharmaceuticalsbuyer$64,527,1564.73%
Loading chart...
Loading chart...
Trade Data
Data SourceHS CodeDescriptionBuyerBuyer CountrySellerSeller Country
16 September 2025PH30043100000Ozempic 1Mg 1Pc. With Nf Plus 4Pcs. - 123,440 EaNovo Nordisk Pharmaceuticals PhilippinesPHNovo Nordisk As$8,845,820.36
26 April 2022RU3004900002Medicines Not Containing Antibiotics, Hormones, Alkaloids, Vitamins, Iodine Or Iodine Compounds: Saxendar (Liraglutide) Solution For Subcutaneous Introduction 6 Mg / Ml (Cartridge In Syringe-Pen) 3 Mlh3 (Pack. Cart.) - 51360 Pack., Series Do, Mp5b03Novo Nordisk LlcRUNovo Nordisk As$7,485,030.00
20 July 2022RU3004310000Medicines For Medical Use Packed In Dosage Forms Not Packed For Retail, Not For Veterinary:Novo Nordisk LlcRUNovo Nordisk As$6,150,840.00
24 November 2022RU3004310000Medicines For Medical Use Packed In Dosage Forms Not Packed For Retail, Not For Veterinary:Novo Nordisk LlcRUNovo Nordisk As$5,837,190.00
12 March 2018RU2937120000Insulin And Its Salts. Pharmaceutical Substance. Is Intended For The Production Of Drugs For Medical Use (And Exactly: Production Of A Ready Dosage Form Of Solutions And Suspensions For Subcutaneous And Intravenous Administration, Insulin DeNovo Nordisk LlcNovo Nordisk As$5,708,443.90
27 March 2025PH30043100000Ozempic 1.5 Ml 0.5 Mg With Nf Plus 4 Pcs - 79,715 EaNovo Nordisk Pharmaceuticals PhilippinesPHNovo Nordisk As$5,687,858.45
21 October 2022RU3004310000Medicines For Medical Use Packed In Dosage Forms Not Packed For Retail, Not For Veterinary:Novo Nordisk LlcRUNovo Nordisk As$5,532,080.00
16 July 2018RU2937120000Insulin And Its Salts. Pharmaceutical Substance. Intended For Production Of Medicinal Products For Medical Use (And Exactly: Production Of A Ready Dosage Form Of Solutions And Suspensions For Subcutaneous And Intravenous Administration, Primary Package) Not For Retail, Does Not Contain Alcohol, Not For Veterinary Medicine: Insulin Aspart, Crystalline Powder. Series Gq1ahp046. Valid Until 14.02.2022 Register Number: Фс-000844 Dated 05.22.17 Insulin Detemir, Crystalline Powder. Series Gdfdhp217. Valid Until 08/20/2022 Register Number: Фс-001313 Of 01/14/16 Insulin Detemir, Crystalline Powder. Series Gdfdhp218. Valid Until 21.08.2022 Register Number: Фс-001313 Of 14.01.16 Insulin Detemir, Crystalline Powder. Series Gdfdhp227. Valid Until 08/28/2022 Register Number: Фс-001313 Of 01/14/16Novo Nordisk LlcRUNovo Nordisk As$5,148,870.39
25 August 2021RU2937120000Insulin And Its Salts.â Pharmaceutical Substance.â Prepared For The Production Of Medicinal Products For Medical UseNovo Nordisk LlcRUNovo Nordisk As$4,871,320.00
25 August 2020RU2937120000Insulin And Its Salts. Pharmaceutical Substance. Intended For The Production Of Drugs For Medical Use (And That Is: Production Of A Ready Dosage Form Of Solutions And Suspensions For Subcutaneous And Intravenous AdministrationNovo Nordisk LlcRUNovo Nordisk As$4,860,521.05
0 of 20 row(s) selected.